(Q36466544)

14 August 2017

Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation (English)

1 reference

14 August 2017

1 reference

1 reference

Combaret V

1

1 reference

14 August 2017

Favrot MC

2

1 reference

14 August 2017

Kremens B

3

1 reference

14 August 2017

Philip I

4

1 reference

14 August 2017

Bailly C

5

1 reference

14 August 2017

Fontaniere B

6

1 reference

14 August 2017

Gentilhomme O

7

1 reference

14 August 2017

Chauvin F

8

1 reference

14 August 2017

Zucker JM

9

1 reference

14 August 2017

Bernard JL

10

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 June 1989

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

59

1 reference

14 August 2017

6

1 reference

14 August 2017

844-847

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1989.180

14 August 2017

0 references

cites work

Phenotypic and functional heterogeneity of human cloned natural killer cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246735

Detection of bone marrow invasion by neuroblastoma is improved by sampling at two sites with both aspirates and trephine biopsies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246735

Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246735

Experimental evaluation of an immunomagnetic bone marrow purging procedure using the Burkitt lymphoma model

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246735

S-L 11.14: a monoclonal antibody recognizing neuroectodermal tumors with possible value for bone marrow purging before autograft

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246735

High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246735

Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246735

High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246735

Diagnosis of human lymphoma with monoclonal antileukocyte antibodies.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246735

A phase II study of high-dose cisplatin and VP-16 in neuroblastoma: a report from the Société Française d'Oncologie Pédiatrique

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246735

Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246735

Detection of small cell lung cancer bone marrow involvement by discontinuous gradient sedimentation

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246735

Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres

28 June 2018

1 reference

12 December 2020

Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution

1 reference

12 December 2020

Metastatic neuroblastoma managed by supralethal therapy and bone marrow reconstitution (BMRc). Results of a four-institution Children's Cancer Study Group pilot study

1 reference

12 December 2020

A method of detecting neuroblastoma in human bone marrow by means of two monoclonal antibodies PI 153/3 and KE2

1 reference

12 December 2020

The value of bone marrow trephine biopsy in the diagnosis of metastatic neuroblastoma

1 reference

12 December 2020

High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age

1 reference

12 December 2020

Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma

1 reference

12 December 2020

The significance of immunological analysis for the detection of residual neuroblasts in bone marrow

1 reference

12 December 2020

Detection of minimal malignant cell infiltration in the bone marrow of patients with solid tumours, non-Hodgkin lymphomas and leukaemias

1 reference

12 December 2020

Use of panels of monoclonal antibodies in the differential diagnosis of neuroblastoma and lymphoblastic disorders

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1989.180

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

2660896

1 reference